Search clinical trials for: MORAb-003 (farletuzumab)

Total 2709 results

Orion Corporation, Orion Pharma

Completed

Safety and Tolerability of ODM-203 in Subjects With Advanced Solid Tumours (KIDES-203)

Solid Tumours

France, Finland, Spain, Italy, Denmark, United Kingdom
Suzhou Yabao Pharmaceutical R&D Co., Ltd.

Completed

Single Ascending Oral Doses of SY-009 in Healthy Subjects

Diabetes

China
Suzhou Yabao Pharmaceutical R&D Co., Ltd.

Completed

Single Ascending Oral Doses of SY-008 in Healthy Subjects

Diabetes

China
Altor BioScience

Completed

QUILT-1.004: A Single Center, Open-label, Pharmacokinetic Study of Subcutaneous ALT-803

Healthy

United States
Altor BioScience
National Cancer Institute (NCI)

Completed

A Phase 1 Study of the Clinical and Immunologic Effects of ALT-803 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

United States
Stemcentrx

Terminated

SC-002 in Small Cell Lung Cancer and Large Cell Neuroendocrine Carcinoma

Small Cell Lung Cancer

United States
Pharmaceutical Project Solutions, Inc.
Cognitive Research Corporation

Completed

Pharmacokinetic Study of Intranasal RX0041-002 in Hepatic-Impaired Individuals and Subjects With Normal Hepatic Function

Analgesic Allergy

United States
Genentech, Inc.

Completed

A Bioavailability and Pharmacokinetic Study of GDC-0032 in Healthy Volunteers

Healthy Volunteer

United States
Schiffler Cancer Center

Completed

Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial

Prostatic Neoplasm

United States
Cerenis Therapeutics, SA

Completed

Exploratory Study of Plaque Regression (EXPRESS)

Heterozygous Familial Hypercholesterolemia

Canada
Argos Therapeutics

Completed

A Single-Patient Study Using AGS 006

Pancreatic Cancer

United States
M.D. Anderson Cancer Center
Cellectar Biosciences, Inc.

Withdrawn

NOV-002 in Myelodysplastic Syndrome (MDS)

Leukemia | Myelodysplastic Syndrome
Kowa Research Institute, Inc.

Completed

A Multicenter, Open Label, Single Dose Study to Evaluate the Effect of Renal Insufficiency on the Pharmacokinetics of SK 0403

Type 2 Diabetes Mellitus

United States
Danube Pharmaceuticals, Inc.

Completed

Safety, Efficacy, and Pharmacokinetic Profile of DNB-001 in Subjects With Elevated Intraocular Pressure (DNB-001)

Ocular Hypertension | Glaucoma | Elevated IOP

United Kingdom
IDEA AG

Completed

IDEA-033 Open Label Study

Joint Pain | Musculoskeletal Pain | Stiffness | Soft Tissue Inflammation in Designated Target Area(s)

Germany
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

Phase II Dose-Finding Study of SK-0403 With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Japan
Memory Pharmaceuticals
Stanley Medical Research Institute

Completed

Safety and Efficacy of MEM 1003 Versus Placebo for the Treatment of Patients With Bipolar I Disorder

Bipolar Disorder With Manic or Mixed Episodes

United States
JADO Technologies GmbH

Completed

Efficacy and Safety of TF002 in Cutaneous Mastocytosis

Cutaneous Mastocytosis

Germany
Stoke Therapeutics, Inc

Completed

An Open-Label Study to Investigate the Safety of Single and Multiple Ascending Doses in Children and Adolescents With Dravet Syndrome

Dravet Syndrome

United States
AbbVie

Completed

A Study to Assess the Relative Bioavailability of Immediate Release Formulations of ABBV-903 in Healthy Adult Participants

Healthy Volunteer

United States
Rhodes Pharmaceuticals, L.P.
Purdue Pharma LP

Completed

PRC-063 in an ADULT Workplace Environment

Attention Deficit Hyperactivity Disorder (ADHD)

United States
GlaxoSmithKline

Completed

Study to Evaluate the Safety, Tolerability and Pharmacokinetic of Single and 14 Day Repeat Topical Application of GSK1940029

Acne Vulgaris

Australia
ImmunityBio, Inc.

Recruiting

Single Center Study Of N-803 Stimulation On Expansion, Enrichment, Proliferation Of Natural Killer Cells Collected By Apheresis

Healthy Subjects

United States
ImmunoGenesis

Recruiting

Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors

Solid Tumor

United States
Fog Pharmaceuticals, Inc.

Recruiting

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Cancer | Gastric Cancer | Colorectal Cancer | Solid Tumor | Metastatic Cancer | Adenomatous Polyposis Coli | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non-small Cell Carcinoma | Locally Advanced Solid Tumor | Non-small Cell Lung Cancer Stage IIIB | Gastroesophageal-junction Cancer | Non-Small... and other conditions

United States
PYC Therapeutics

Recruiting

SAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Platypus)

Retinal Dystrophy | PRPF31 Mutationassociated Retinal Dystrophy | RP11

United States
Medibio Limited

Recruiting

Sleep Signal Analysis for Current Major Depressive Episode (SAMDE) (SAMDE)

Depressive Disorder | Depression | Depressive Disorder, Major | Depressive Episode | Depression Mild

United States
CellabMED

Recruiting

A Clinical Study of IL13Rα2 Targeted CAR-T in Patients With Malignant Glioma (MAGIC-I)

Recurrent Malignant Glioma

Korea, Republic of
ICM Co. Ltd.

Not yet recruiting

A Study Evaluating the Safety, Tolerability, and Activity of ICM-203 in Subjects With Knee Osteoarthritis.

Osteoarthritis, Knee
Cloudbreak Therapeutics, LLC

Recruiting

Safety and Efficacy Study of CBT-004 in Patients With Vascularized Pinguecula

Pinguecula

United States
PharmaMatrix Holdings Ltd
University of Alberta

Recruiting

A Study of CCI-001 in Patients With Recurrent and/or Metastatic Solid Tumours

Cancer: Recurrent and/or Metastatic Solid Tumours

Canada
Toray Industries, Inc

Recruiting

Pilot Clinical Study of NOA-001 for ARDS (Acute Respiratory Distress Syndrome)

Acute Respiratory Distress Syndrome

Japan
Videregen Limited
Royal Free Hospital NHS Foundation Trust; Papworth Hospital NHS Foundation... and other collaborators

Not yet recruiting

ENgineered Tissue Repair of BronchopleUral fiSTula (ENTRUST)

Bronchopleural Fistula
Alumis Inc

Active, not recruiting

Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Plaque Psoriasis

Plaque Psoriasis

United States, Canada
ImmuneOncia Therapeutics Inc.

Completed

A Study of IMC-002 in Subjects With Metastatic or Locally Advanced Solid Tumors and Relapsed or Refractory Lymphomas

Lymphoma | Solid Tumor

Korea, Republic of, United States
Alumis Inc

Active, not recruiting

POC Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Active Intermediate, Posterior, or Pan NIU (OPTYK-1)

Uveitis, Intermediate | Noninfectious Panuveitis | Uveitis Posterior Non-Infectious

United States
Compass Therapeutics

Active, not recruiting

A Study of CTX-009 in Adult Patients With Metastatic Colorectal Cancer (COMPANION-003)

Metastatic Colorectal Cancer | Rectal Cancer | Colon Cancer

United States
Takeda

Active, not recruiting

A Study of TAK-103 in Adult With Solid Tumors

Solid Tumors

Japan
LogicBio Therapeutics, Inc
Alexion Pharmaceuticals, Inc.

Active, not recruiting

Long-term Follow-up Study of Patients Who Received hLB-001 Gene Therapy

Methylmalonic Acidemia

United States
Rohto Pharmaceutical Co., Ltd.

Active, not recruiting

A Study to Investigate the Safety and Efficacy of UC-MSCs in Pediatric Patients With Cerebral Palsy

Cerebral Palsy | Periventricular Leukomalacia

Japan
Antengene Therapeutics Limited

Terminated

Dual TORC1/TORC2 Inhibitor ATG-008 (CC-223) in HBV Positive Advanced Hepatocellular Carcinoma (HCC) Subjects

Hepatocellular Carcinoma

Korea, Republic of, Taiwan, China
Oblato, Inc.

Active, not recruiting

Clinical Trial of IV OKN-007 in a Pilot Cohort of Human Recurrent Malignant Glioma Patients (OKN-007)

Recurrent Malignant Glioma

United States
Acceleron Pharma Inc. (a wholly owned subsidiary...

Terminated

Extension Study to Evaluate the Long-Term Effects of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) and Charcot-Marie Tooth (CMT) Disease Types 1 and X (CMT1 and CMTX)

Charcot-Marie-Tooth Disease | Facioscapulohumeral Muscular Dystrophy

United States, Spain, Canada
Celularity Incorporated
Lung Biotechnology PBC; California Institute for Regenerative Medicine (CIRM); ID...

Active, not recruiting

Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 (CYNKCOVID)

Coronaviridae Infections | Nidovirales Infections | RNA Virus Infections | Respiratory Tract Infections | Coronavirus Infection | Pneumonia, Viral | Pneumonia | Lung Diseases | ARDS | Coronavirus | Severe Acute Respiratory Syndrome Coronavirus 2 | Respiratory Tract Disease | Virus Disease | Physiological Effects of... and other conditions

United States
Shanton Pharma Co., Ltd.

Completed

Placebo Controlled, Dose Escalation Study to Evaluate Safety, Pharmacokinetics & Efficacy of SAP-001 in Gout Patients

Gout, Hyperuricemia

United States
Teijin America, Inc.

Completed

A Study to Evaluate Safety and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation

Lumbar Disc Herniation

United States
RSP Systems A/S

Completed

Non-invasive Glucose Measurement With Raman Technology in Patients With Type 1 and Type 2 Diabetes

Diabete Mellitus | Medical Device

Germany
Advaxis, Inc.

Completed

ADXS11-001 High Dose HPV+ Cervical Cancer

Effects of Immunotherapy | Cervical Adenocarcinoma | Cervical Squamous Cell Carcinoma | Cervical Small Cell Carcinoma | Stage III Cervical Cancer | Stage IVA Cervical Cancer | Stage IVB Cervical Cancer | Metastatic/Recurrent Cervical Cancer | Cervical Adenosquamous Cell Carcinoma

United States
AbbVie

Terminated

A Study of SC-005 in Subjects With Triple Negative Breast Cancer (TNBC)

Breast Cancer

United States
Masonic Cancer Center, University of Minnesota
University of Minnesota

Withdrawn

QUILT-3.034: Non-Myeloablative TCRa/b Deplete Haplo HSCT With Post ALT-803 for AML

Secondary Acute Myeloid Leukemia | Myelodysplastic Syndrome | Treatment-Related Acute Myeloid Leukemia | High-Risk Acute Myeloid Leukemia

United States

Search clinical trials for: MORAb-003 (farletuzumab)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations